-+ 0.00%
-+ 0.00%
-+ 0.00%

Goldman Sachs Maintains Neutral on Cerence, Lowers Price Target to $8

Benzinga·02/09/2026 17:20:20
Listen to the news
Goldman Sachs analyst Mark Delaney maintains Cerence (NASDAQ:CRNC) with a Neutral and lowers the price target from $11 to $8.